<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02077530</url>
  </required_header>
  <id_info>
    <org_study_id>MS in KUMC</org_study_id>
    <nct_id>NCT02077530</nct_id>
  </id_info>
  <brief_title>Metabolic Syndrome Cohort in Korea</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University Anam Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University Anam Hospital</source>
  <brief_summary>
    <textblock>
      Patients with metabolic syndrome living in Seoul area are included in this prospective
      registry for more than 10 years. All enrolled patients undergo thorough medical history
      survey. Enrolled patients will have coronary CT, 2D echocardiogram, treadmill test, pulse
      wave velocity, augmentation index, carotid intima-media thickness, and abdominal fat mass
      evaluation. Moreover, lipid profiles and inflammatory markers such as hsCRP, IL-6, TNF-alpha,
      VCAM-1, ICAM-1, adiponectin, MMP-9 will be measured. All participants will repeat the test
      and survey every year in Korea University Hospital.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2023</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Cardiovascular events</measure>
    <time_frame>10 years</time_frame>
    <description>Cardiovascular events such as fatal and non-fatal myocardial infarction, heart failure, need for coronary and peripheral revascularization, stroke, all-cause death, and cardiac death.</description>
  </primary_outcome>
  <enrollment type="Actual">1500</enrollment>
  <condition>Metabolic Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with metabolic syndrome living in Seoul area
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: 3 out of 5 criteria

          -  Central obesity: Men ≥ 90 cm Women ≥ 85 cm

          -  Plasma triglycerides ≥ 150 mg/dL

          -  HDL cholesterol Men &lt; 40 mg/dL, Women &lt; 50 mg/dL

          -  Blood pressure ≥130/85 mm Hg (or treatment for hypertension)

          -  Fasting plasma glucose ≥ 100 mg/dL

          -  Age between 30 to 64

          -  Consent to our registry protocol

        Exclusion Criteria:

          -  Patients who could not undergo coronary CT, 2D echocardiogram, treadmill test, and
             pulse wave velocity.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Korea University Anam Hospital Metabolic Syndrome Research Center</name>
      <address>
        <city>Seoul</city>
        <zip>136-705</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 2, 2014</study_first_submitted>
  <study_first_submitted_qc>March 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 4, 2014</study_first_posted>
  <last_update_submitted>April 24, 2019</last_update_submitted>
  <last_update_submitted_qc>April 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Korea University Anam Hospital</investigator_affiliation>
    <investigator_full_name>Soon Jun Hong</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Patients with metabolic syndrome age between 30 to 64: Central obesity (Men ≥ 90 cm Women ≥ 85 cm), Plasma triglycerides ≥ 150 mg/dL</keyword>
  <keyword>HDL cholesterol Men &lt; 40 mg/dL, Women &lt; 50 mg/dL, Blood pressure ≥130/85 mm Hg (or treatment for hypertension),</keyword>
  <keyword>Fasting plasma glucose ≥ 100 mg/dL</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

